CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

CSF2; GMCSF; Sargramostim; Molgramostin; Granulocyte-Macrophage Colony Stimulating Factor

  • CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Packages (Simulation)
  • CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Packages (Simulation)
  • CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Results demonstration
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

This assay has high sensitivity and excellent specificity for detection of Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF).
No significant cross-reactivity or interference between Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) and analogues was observed.

Recovery of the CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

Matrices listed below were spiked with certain level of recombinant Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) and the recovery rates were calculated by comparing the measured value to the expected amount of Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 83-92 86
EDTA plasma(n=5) 93-101 97
heparin plasma(n=5) 92-101 96

Precision of the CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-105% 97-105% 91-99% 87-101%
EDTA plasma(n=5) 95-103% 81-96% 78-103% 89-99%
heparin plasma(n=5) 78-98% 79-93% 96-104% 80-105%

Stability of the CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)

The microplate provided in this kit has been pre-coated with an antibody specific to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) level in the sample or standard.;

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
APA045Ra61 Active Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Cell culture; Activity Assays.
EPA045Ra61 Eukaryotic Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Positive Control; Immunogen; SDS-PAGE; WB.
APA045Ra01 Active Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Cell culture; Activity Assays.
RPA045Ra01 Recombinant Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Positive Control; Immunogen; SDS-PAGE; WB.
PAA045Ra01 Polyclonal Antibody to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) WB; IHC; ICC; IP.
MAA045Ra21 Monoclonal Antibody to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) WB; IHC; ICC; IP.
SEA045Ra ELISA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA045Ra CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) Chemiluminescent immunoassay for Antigen Detection.
LMA045Ra Multiplex Assay Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK